Brii Biosciences Ltd (2137)

Hong Kong
Currency in HKD
2.59
+0.02(+0.78%)
Closed
2137 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.422.63
52 wk Range
0.802.85
Key Statistics
Edit
Bid/Ask
2.59 / 2.59
Prev. Close
2.57
Open
2.57
Day's Range
2.42-2.63
52 wk Range
0.8-2.85
Volume
6.23M
Average Volume (3m)
5.78M
1-Year Change
167.01%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2137 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
0.98
Downside
-62.14%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

Brii Biosciences Company Profile

Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, BRII-835, and BRII-877, which are in Phase 2 the development of a functional cure for HBV for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 2; and BRII-732 that is in Phase 1 clinical trial and BRII-753, which is in preclinical stage for the treatment of HIV. It develops BRII-296 for the treatment of PPD/MDD, anxiety, and other depressive disorders; BRII-297 for treatment of various depressive disorders; BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for oral treatment for patients with chronic NTM lung disease. Brii Biosciences Limited was incorporated in 2017 and is headquartered in Beijing, China.

Compare 2137 to Peers and Sector

Metrics to compare
2137
Peers
Sector
Relationship
P/E Ratio
−6.6x−7.4x−0.5x
PEG Ratio
−0.350.030.00
Price/Book
0.6x2.7x2.6x
Price / LTM Sales
45.7x12.2x3.0x
Upside (Analyst Target)
−62.1%13.0%56.3%
Fair Value Upside
Unlock11.1%10.0%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.98
(-62.14% Downside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Brii Biosciences (2137) Stock Price Today?

The Brii Biosciences stock price today is 2.59.

What Stock Exchange Does Brii Biosciences Trade On?

Brii Biosciences is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Brii Biosciences?

The stock symbol for Brii Biosciences is "2137."

What Is the Brii Biosciences Market Cap?

As of today, Brii Biosciences market cap is 1.88B.

What is Brii Biosciences Earnings Per Share?

The Brii Biosciences EPS is -0.364.

From a Technical Analysis Perspective, Is 2137 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.